Enzon Pharmaceuticals, Inc.
ENZN
$0.0998
$0.000.00%
OTC PK
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 0.48% | 0.87% | 0.52% | -2.18% | 0.98% |
Total Receivables | -- | -- | -- | -- | -- |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -- | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -13.06% | -17.60% | -14.97% | 45.32% | 0.61% |
Total Current Assets | 0.39% | 0.71% | 0.36% | -1.85% | 0.97% |
|
|||||
Total Current Assets | 0.39% | 0.71% | 0.36% | -1.85% | 0.97% |
Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -94.44% | -14.04% | -1.11% | 0.28% | 223.42% |
Total Assets | -0.23% | 0.60% | 0.35% | -1.83% | 1.50% |
|
|||||
Total Accounts Payable | 0.00% | 0.00% | 0.00% | 0.00% | -1.78% |
Total Accrued Expenses | -33.66% | 71.19% | -67.93% | 100.00% | 37.31% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 21,233.33% | -70.00% | 233.33% | -99.54% | 64,450.00% |
Total Other Current Liabilities | 21,233.33% | -70.00% | 233.33% | -99.54% | 64,450.00% |
Total Current Liabilities | 283.11% | 6.83% | -21.31% | -69.60% | 322.17% |
|
|||||
Total Current Liabilities | 283.11% | 6.83% | -21.31% | -69.60% | 322.17% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 283.11% | 6.83% | -21.31% | -69.60% | 322.17% |
|
|||||
Common Stock & APIC | 0.44% | -0.73% | -0.72% | -0.72% | 0.43% |
Retained Earnings | -0.10% | 0.36% | 0.39% | 0.45% | 0.94% |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | 8.91% | -9.11% | -7.74% | -6.02% | 39.36% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -3.61% | 1.22% | 1.23% | 1.25% | -3.61% |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -3.61% | 1.22% | 1.23% | 1.25% | -3.61% |
|
|||||
Total Common Equity | 8.91% | -9.11% | -7.74% | -6.02% | 39.36% |
Total Preferred Equity | -3.61% | 1.22% | 1.23% | 1.25% | -3.61% |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -2.88% | 0.55% | 0.60% | 0.70% | -1.29% |
|